Stem Cells — Potency, Sources and Uses
Spec Mapping: This lesson is mapped to OCR H420 Module 2.1.6 — Cell division, diversity and cellular organisation (refer to the official OCR H420 specification document for exact wording). It develops stem-cell potency (totipotent, pluripotent, multipotent, unipotent), sources (embryonic, adult, cord, iPS), therapeutic uses, and the ethical considerations of stem-cell research, framed in neutral academic register.
If every cell in your body is descended from a single fertilised egg, then at some point that original cell — and its early descendants — had the potential to become any cell type. Such cells are called stem cells, and they are of enormous biological and medical importance. This lesson develops the OCR H420 Module 2.1.6 content on stem cells, their uses and the ethical considerations surrounding them.
1. What Is a Stem Cell?
Key Definition — Stem Cell: An undifferentiated cell capable of both self-renewal (dividing to produce more stem cells) and differentiation (giving rise to specialised cell types).
Two defining features:
- Self-renewal — a stem cell can divide to produce at least one daughter that is also a stem cell. This maintains the stem cell population indefinitely.
- Potency — a stem cell can differentiate into one or more mature cell types.
Stem cells exist at all stages of life. A zygote is a stem cell. Early embryonic cells are stem cells. And adult tissues contain small populations of stem cells that provide cells for ongoing renewal (of blood, skin, gut, etc.).
2. Levels of Potency
Stem cells are classified by how many cell types they can produce — a property called potency. Four levels are recognised.
graph TD
A["Totipotent<br/>any cell type including placenta<br/>zygote and first few cells"] --> B["Pluripotent<br/>any body cell type but not placenta<br/>inner cell mass of blastocyst"]
B --> C["Multipotent<br/>several related types<br/>haematopoietic stem cells"]
C --> D["Unipotent<br/>one type only<br/>satellite cells in muscle"]
2.1 Totipotent
Totipotent cells can differentiate into any cell type, including extra-embryonic tissues such as the placenta and umbilical cord. The only naturally totipotent cells are the zygote and the cells produced by the first few cleavage divisions (up to the 8-cell stage in humans). Totipotent cells can form a complete organism.
2.2 Pluripotent
Pluripotent cells can differentiate into any cell type of the body (all three germ layers — endoderm, mesoderm, ectoderm) except the placenta. They cannot form a complete organism on their own. The classic example is cells from the inner cell mass of the blastocyst (the 5-day-old embryo) — these are the source of embryonic stem cells (ESCs) in research.
2.3 Multipotent
Multipotent cells can differentiate into several (but limited) related cell types — usually within one tissue or lineage. They are the main type of adult stem cell.
Examples:
- Haematopoietic stem cells in bone marrow → all blood cells (red cells, white cells, platelets).
- Mesenchymal stem cells → bone, cartilage, fat cells.
- Neural stem cells → neurones, astrocytes, oligodendrocytes.
2.4 Unipotent
Unipotent cells can produce only one cell type, but they can still self-renew (which distinguishes them from fully specialised cells).
Examples:
- Epidermal stem cells produce new skin keratinocytes.
- Satellite cells in skeletal muscle produce new muscle cells for growth and repair.
- Cardiomyocyte progenitor cells — once thought not to exist in adult heart, but now believed to maintain a very slow turnover of cardiac muscle.
3. Sources of Stem Cells
3.1 Embryonic Stem Cells (ESCs)
- Source: Inner cell mass of the blastocyst (5-day-old embryo), typically leftover embryos from IVF.
- Potency: Pluripotent.
- Advantages: Can become virtually any cell type; divide readily in culture; powerful research and therapeutic potential.
- Disadvantages: Destroying an embryo to harvest them is ethically controversial. They may be rejected by the patient's immune system because they are genetically different (allogeneic). They can also form teratomas (disorganised tumours) if injected without proper differentiation.
3.2 Adult (Tissue/Somatic) Stem Cells
- Source: Various tissues — bone marrow, skin, intestinal crypts, hair follicles, brain, muscle.
- Potency: Multipotent or unipotent.
- Advantages: Already used clinically (bone marrow transplants for leukaemia); no embryo destruction; can be autologous (from the patient themselves, avoiding rejection).
- Disadvantages: Limited potency; harder to isolate and culture; lower division rate than ESCs.
3.3 Plant Meristems
Plants have stem cells too. The apical meristems (at the tips of roots and shoots) contain cells that continue to divide throughout the plant's life, producing new tissues. Lateral meristems (cambia) provide for growth in girth. These meristematic cells are often totipotent — a feature exploited in plant tissue culture, where a single cell can be grown into a whole new plant.
3.4 Umbilical Cord and Cord Blood
Blood from the umbilical cord is rich in haematopoietic stem cells and can be banked at birth for future medical use. It has lower risk of immune rejection than adult stem cells and raises fewer ethical concerns than embryonic sources.
3.5 Induced Pluripotent Stem Cells (iPSCs)
A more recent development (2006, Shinya Yamanaka) — adult cells can be reprogrammed to a pluripotent state by introducing a small number of transcription factor genes (originally Oct4, Sox2, Klf4, c-Myc). iPSCs behave much like embryonic stem cells but are generated from the patient's own cells — sidestepping both ethical objections and immune rejection. Yamanaka won the 2012 Nobel Prize for this work. iPSCs are now the focus of much regenerative medicine research.
| Source | Potency | Key pros | Key cons |
|---|
| Embryonic (ESCs) | Pluripotent | Very versatile; easy to grow | Ethical; immune rejection; tumour risk |
| Adult (bone marrow) | Multipotent | Ethically safer; used clinically | Limited potency; hard to culture |
| Umbilical cord blood | Multipotent | Easy collection; low rejection | Limited cell number |
| Plant meristems | Totipotent (most) | Unique to plants; enables propagation | N/A for medicine |
| iPSCs | Pluripotent | Patient-specific; no embryo | Risk of genomic instability |
4. Potential Therapeutic Uses of Stem Cells
Stem cell therapies exploit the ability to generate new tissue to replace damaged or lost cells. A few examples:
- Leukaemia and lymphoma — bone marrow transplants replace diseased blood-forming cells with healthy donor cells. Already routine clinical practice.
- Burns — skin stem cells can be cultured to form grafts for severe burn patients.
- Parkinson's disease — researchers aim to produce dopamine-producing neurones to replace those lost to the disease.
- Type 1 diabetes — producing insulin-secreting β-cells to restore blood glucose control.
- Spinal cord injury — producing neurones and glial cells to rebuild damaged cord tissue.
- Heart failure — replacing dead cardiac muscle after a heart attack with new cardiomyocytes.
- Macular degeneration — producing retinal pigment epithelium cells to restore sight.
- Genetic blood disorders (sickle cell, thalassaemia) — transplanting corrected haematopoietic stem cells.
Most of these applications are still experimental. Bone marrow transplantation, corneal stem cell grafts and certain skin grafts are the mainstream examples in routine clinical use.
5. Research Uses of Stem Cells
Beyond therapy, stem cells are invaluable for:
- Studying development — watching how cells specialise reveals the fundamental logic of biology.
- Modelling disease — iPSCs from patients with genetic disorders can be differentiated into affected cell types, allowing scientists to study the disease in a dish.
- Drug testing — new drugs can be tested on stem-cell-derived heart or liver cells, reducing reliance on animal testing.
- Toxicology — screening chemicals for toxicity.
- Gene therapy research — correcting mutations in stem cells before transplant.
6. Ethical Considerations
Stem cell research, especially using embryonic stem cells, raises serious ethical questions. Exam questions often ask you to weigh up arguments for and against.
6.1 Arguments For
- Could cure diseases that currently have no effective treatment.
- Could save many lives and improve quality of life for millions.
- Embryos used in ESC research are typically spare IVF embryos that would otherwise be discarded.
- Research is tightly regulated in the UK (by the Human Fertilisation and Embryology Authority, HFEA).
- Alternatives (iPSCs, adult stem cells, cord blood) are increasingly available and reduce the need for embryonic sources.
6.2 Arguments Against
- Destroying an embryo to harvest stem cells may be seen as destroying a potential human life, depending on one's moral or religious views.
- Commercialisation of embryos or stem cell lines raises concerns about exploitation.
- Long-term safety is not yet established — stem cells can form tumours or be rejected.
- Some religions consider human life to begin at conception; research on embryos is fundamentally objectionable on that view.
- Consent is complex — donors of spare IVF embryos may not fully grasp future uses.
UK law allows research on embryos up to 14 days after fertilisation (before the primitive streak forms, which marks the beginning of the nervous system). After 14 days, such research is illegal.
6.3 Why iPSCs Are a Partial Solution
Induced pluripotent stem cells resolve many ethical objections because they do not require embryos at all. Critics note, however, that iPSCs can still form tumours, may carry genetic changes from the reprogramming process, and cannot be used to form totipotent or early-embryo stages.
7. Common Exam Mistakes
- Saying stem cells are "undifferentiated cells". Correct, but incomplete — they also self-renew. Always mention both features.
- Confusing totipotent and pluripotent. Totipotent includes extra-embryonic tissues; pluripotent does not.
- Claiming adult stem cells are pluripotent. Most are multipotent, with a few unipotent.
- Saying iPSCs are "embryonic stem cells". They are not — they are adult cells reprogrammed to a pluripotent state.
- Failing to mention ethical arguments on both sides when asked.
- Writing that stem cells can "cure any disease". They have potential but most therapies are still experimental.
- Confusing stem cells with cancer cells. Both can divide indefinitely, but cancer cells have lost growth control, while stem cells remain regulated.
- Forgetting that plants also have stem cells (meristems), not just animals.
8. Exam-Style Questions
- Explain what is meant by the terms totipotent, pluripotent and multipotent stem cells. Give an example of each. (6)
- Compare embryonic stem cells with induced pluripotent stem cells (iPSCs). (4)
- Discuss the ethical arguments for and against the use of embryonic stem cells in medical research. (6)
- Describe two potential therapeutic uses of stem cells, other than bone marrow transplantation. (4)
Model answer for (1):
"A totipotent stem cell can differentiate into any cell type, including extra-embryonic tissues such as the placenta, and can form a whole organism. Example: the zygote and the cells of the first few cleavage divisions. A pluripotent stem cell can differentiate into any body cell type but not extra-embryonic tissues. Example: cells of the inner cell mass of the blastocyst (embryonic stem cells). A multipotent stem cell can differentiate into several (limited) related cell types within a lineage. Example: haematopoietic stem cells in bone marrow, which produce all types of blood cell."
Summary
- Stem cells are undifferentiated cells that can both self-renew and differentiate.
- Potency describes how many cell types a stem cell can produce: totipotent > pluripotent > multipotent > unipotent.
- Embryonic stem cells (from the inner cell mass) are pluripotent and powerful but raise ethical concerns.
- Adult stem cells are multipotent or unipotent, ethically safer, and already used clinically (bone marrow transplants).
- Umbilical cord blood is a useful source of haematopoietic stem cells.
- Induced pluripotent stem cells (iPSCs) are adult cells reprogrammed to pluripotency — a breakthrough that reduces ethical concerns.
- Plant meristems contain stem cells and are often totipotent.
- Potential therapies include treatment of leukaemia, burns, Parkinson's, diabetes, spinal injury, heart disease and blindness.
- Ethical debate centres on the status of the embryo and the destruction of potential human life, balanced against the benefits of research.
9. Stem Cell Niche — The Microenvironment
A modern A-Level understanding goes beyond classifying potency to recognising that stem cells exist within a stem cell niche — a specialised microenvironment that maintains their stemness through:
- Local signalling — niche cells produce ligands (Wnt, Notch, BMP, FGF, hedgehog) that keep stem cells undifferentiated.
- Physical contact — adherens junctions and cadherin-based cell-cell adhesion anchor stem cells in position.
- Extracellular matrix — laminin, collagen and fibronectin provide a substrate with the right mechanical stiffness; very stiff matrix biases towards bone, soft matrix towards neural fate.
- Oxygen tension — many stem cell niches are hypoxic (lower O₂), which protects stem cells from oxidative DNA damage during their long lifespan.
- Asymmetric cell division — stem cells divide asymmetrically so that one daughter inherits the niche-contact and remains a stem cell, while the other daughter loses contact and begins to differentiate.